Candel Therapeutics (CADL) Return on Assets (2021 - 2025)

Candel Therapeutics has disclosed Return on Assets across 5 years of filings, most recently posting 0.0% for Q4 2025.

• Return on Assets for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Assets came in at 0.0% for Q4 2025 at Candel Therapeutics, down from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2021 to a low of 0.02% in Q3 2024.
• The 5-year median for Return on Assets is 0.0% (2025), against an average of 0.01%.
• Across the five-year window, Return on Assets fell 1 bps in 2024 and grew 1 bps in 2025, its largest moves.
• Candel Therapeutics' Return on Assets stood at 0.0% in 2021, then sank by 55 bps to 0.0% in 2022, then slumped by 97 bps to 0.01% in 2023, then jumped by 37 bps to 0.01% in 2024, then increased by 21 bps to 0.0% in 2025.
• The last three Return on Assets figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.